Pliant Therapeutics, Inc.
Headquarters country
United States
Registry sponsor category
Industry
- Other names
- Pliant Therapeutics, Inc.
- Company name
- Pliant Therapeutics, Inc.
- Organisation type
- Industry
- Registered legal name
- PLIANT THERAPEUTICS, INC.
- US industry code (SIC)
- Pharmaceutical preparations
- Registry sponsor category
- Industry
- SEC filer number (CIK)
- 0001746473
- Legal Entity Identifier (LEI)
- 5493002Q5LITR7VHZH02
Related records
Trials (8)
- A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CT
- Evaluation of Efficacy and Safety of PLN-74809 in Patients With Idiopathic Pulmonary Fibrosis
- Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19
- Imaging Evaluation of PLN-74809 in Participants With IPF (PLN-74809)
- Phase 2a Evaluation of PLN-74809 on αvβ6 Receptor Occupancy Using PET Imaging in Participants With IPF/
- Phase 2a Evaluation of Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Patients With Primary Sclerosing Cholangitis (PSC)
- Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis